Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-23

Clinical Trial Update: A Analgesic Study of Adductor Canal &IPACK Block with Liposomal Bupivacaine in Knee Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating adductor canal and IPACK nerve blocks using liposomal bupivacaine for unilateral knee arthroplasty. The current status of the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Liposomal Bupivacaine, Postoperative Recovery | Phase 4 | Status: UNKNOWN